[Alkylating agents and antimetabolites in nephrotic syndromes of the infant].
D000477:Alkylating Agents / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D009404:Nephrotic Syndrome / Q000188:drug therapy*
D000477:Alkylating Agents; D000963:Antimetabolites
Les agents alkylants et les antimétabolites dans les syndromes néphrotiques de l'enfant.